Literature DB >> 25965809

Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?

Brian N Dontchos1, Habib Rahbar1, Savannah C Partridge1, Larissa A Korde1, Diana L Lam1, John R Scheel1, Sue Peacock1, Constance D Lehman1.   

Abstract

PURPOSE: To investigate whether qualitative magnetic resonance (MR) imaging assessments of background parenchymal enhancement (BPE), amount of fibroglandular tissue (FGT), and mammographic density are associated with risk of developing breast cancer in women who are at high risk.
MATERIALS AND METHODS: In this institutional review board-approved HIPAA-compliant retrospective study, all screening breast MR images obtained from January 2006 to December 2011 in women aged 18 years or older and at high risk for but without a history of breast cancer were identified. Women in whom breast cancer was diagnosed after index MR imaging comprised the cancer cohort, and one-to-one matching (age and BRCA status) of each woman with breast cancer to a control subject was performed by using MR images obtained in women who did not develop breast cancer with follow-up time maximized. Amount of BPE, BPE pattern (peripheral vs central), amount of FGT at MR imaging, and mammographic density were assessed on index images. Imaging features were compared between cancer and control cohorts by using conditional logistic regression.
RESULTS: Twenty-three women at high risk (mean age, 47 years ± 10 [standard deviation]; six women had BRCA mutations) with no history of breast cancer underwent screening breast MR imaging; in these women, a diagnosis of breast cancer (invasive, n = 12; in situ, n = 11) was made during the follow-up interval. Women with mild, moderate, or marked BPE were nine times more likely to receive a diagnosis of breast cancer during the follow-up interval than were those with minimal BPE (P = .007; odds ratio = 9.0; 95% confidence interval: 1.1, 71.0). BPE pattern, MR imaging amount of FGT, and mammographic density were not significantly different between the cohorts (P = .5, P = .5, and P = .4, respectively).
CONCLUSION: Greater BPE was associated with a higher probability of developing breast cancer in women at high risk for cancer and warrants further study. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2015        PMID: 25965809      PMCID: PMC4554209          DOI: 10.1148/radiol.2015142304

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  25 in total

Review 1.  When can a risk factor be used as a worthwhile screening test?

Authors:  N J Wald; A K Hackshaw; C D Frost
Journal:  BMJ       Date:  1999-12-11

2.  Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study.

Authors:  Karla Kerlikowske; Rebecca A Hubbard; Diana L Miglioretti; Berta M Geller; Bonnie C Yankaskas; Constance D Lehman; Stephen H Taplin; Edward A Sickles
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

3.  Background parenchymal enhancement at breast MR imaging and breast cancer risk.

Authors:  Valencia King; Jennifer D Brooks; Jonine L Bernstein; Anne S Reiner; Malcolm C Pike; Elizabeth A Morris
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

4.  Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?

Authors:  Kavitha Passaperuma; Ellen Warner; Kimberley A Hill; Anoma Gunasekara; Martin J Yaffe
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

5.  Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?

Authors:  Nienke L Hansen; Christiane K Kuhl; Alexandra Barabasch; Kevin Strobel; Simone Schrading
Journal:  J Magn Reson Imaging       Date:  2014-01-21       Impact factor: 4.813

6.  Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Mona Shah; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2011-01-04       Impact factor: 508.702

Review 7.  TLRs: linking inflammation and breast cancer.

Authors:  Khyati Bhatelia; Kritarth Singh; Rajesh Singh
Journal:  Cell Signal       Date:  2014-08-03       Impact factor: 4.315

8.  Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.

Authors:  Catherine S Giess; Eren D Yeh; Sughra Raza; Robyn L Birdwell
Journal:  Radiographics       Date:  2014 Jan-Feb       Impact factor: 5.333

9.  Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.

Authors:  Valencia King; Jennifer Kaplan; Malcolm C Pike; Laura Liberman; D David Dershaw; Carol H Lee; Jennifer D Brooks; Elizabeth A Morris
Journal:  Breast J       Date:  2012-09-25       Impact factor: 2.431

10.  Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study.

Authors:  Simone Schrading; Hans Schild; Marietta Kühr; Christiane Kuhl
Journal:  Radiology       Date:  2013-12-10       Impact factor: 11.105

View more
  60 in total

1.  Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores.

Authors:  Alberto Tagliafico; Bianca Bignotti; Giulio Tagliafico; Simona Tosto; Alessio Signori; Massimo Calabrese
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

2.  Measuring intrarater association between correlated ordinal ratings.

Authors:  Kerrie P Nelson; Thomas J Zhou; Don Edwards
Journal:  Biom J       Date:  2020-06-11       Impact factor: 2.207

3.  Breast density estimation from high spectral and spatial resolution MRI.

Authors:  Hui Li; William A Weiss; Milica Medved; Hiroyuki Abe; Gillian M Newstead; Gregory S Karczmar; Maryellen L Giger
Journal:  J Med Imaging (Bellingham)       Date:  2016-12-28

4.  Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.

Authors:  Jia Wu; Bailiang Li; Xiaoli Sun; Guohong Cao; Daniel L Rubin; Sandy Napel; Debra M Ikeda; Allison W Kurian; Ruijiang Li
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

Review 5.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

Review 6.  Evaluation of background parenchymal enhancement on breast MRI: a systematic review.

Authors:  Bianca Bignotti; Alessio Signori; Francesca Valdora; Federica Rossi; Massimo Calabrese; Manuela Durando; Giovanna Mariscotto; Alberto Tagliafico
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

7.  Fully Automated Convolutional Neural Network Method for Quantification of Breast MRI Fibroglandular Tissue and Background Parenchymal Enhancement.

Authors:  Richard Ha; Peter Chang; Eralda Mema; Simukayi Mutasa; Jenika Karcich; Ralph T Wynn; Michael Z Liu; Sachin Jambawalikar
Journal:  J Digit Imaging       Date:  2019-02       Impact factor: 4.056

8.  Automatic Breast and Fibroglandular Tissue Segmentation in Breast MRI Using Deep Learning by a Fully-Convolutional Residual Neural Network U-Net.

Authors:  Yang Zhang; Jeon-Hor Chen; Kai-Ting Chang; Vivian Youngjean Park; Min Jung Kim; Siwa Chan; Peter Chang; Daniel Chow; Alex Luk; Tiffany Kwong; Min-Ying Su
Journal:  Acad Radiol       Date:  2019-01-31       Impact factor: 3.173

9.  Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways.

Authors:  Jia Wu; Yi Cui; Xiaoli Sun; Guohong Cao; Bailiang Li; Debra M Ikeda; Allison W Kurian; Ruijiang Li
Journal:  Clin Cancer Res       Date:  2017-01-10       Impact factor: 12.531

10.  Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.

Authors:  H Preibsch; L Wanner; S D Bahrs; B M Wietek; K C Siegmann-Luz; E Oberlecher; M Hahn; A Staebler; K Nikolaou; B Wiesinger
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.